Articles citing this paper
Pertussis outbreaks in aged-care facilities
Mark J. Ferson A , Peter W. Robertson B , Anthony M. Brown C and Ala’a Al-Murieb C
+ Author Affiliations
- Author Affiliations
A Public Health Unit, South Eastern Sydney Illawarra Area Health Service and School of Public Health and Community Medicine, University of NSW
B SEALS Area Serology Laboratory, Prince of Wales Hospital and School of Medical Sciences, University of NSW
C Population Health Division, Greater Western Area Health Service
NSW Public Health Bulletin 20(6) 93-94 https://doi.org/10.1071/NB09011
Published: 24 June 2009
2 articles found in Crossref database.
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials
Van Damme Pierre,
McIntyre Peter,
Grimprel Emmanuel,
Kuriyakose Sherine,
Jacquet Jeanne-Marie,
Hardt Karin,
Messier Marc, Van Der Meeren Olivier
Vaccine. 2011 29(35). p.5932
Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): Results of two randomized trials
Weston Wayde M.,
Friedland Leonard R.,
Wu Xiangfeng, Howe Barbara
Vaccine. 2012 30(9). p.1721
